Munafa Stock Market Course + Intraday & FNO calls 
MA NEWS why is Mastercard Incorporated price falling or rising
MA NEWS reasons for why stock price of Mastercard Incorporated is falling or rising
MA Mastercard Incorporated is falling or rising technical reasons
Technical analysis forecast for Mastercard Incorporated Stock is that its in a downtrend for shortterm, and I will avoid taking a BUY or a LONG trade in this stock. Look for opportunities to sell or SHORT Mastercard Incorporated MA at this time. Stock is falling and might fall more.
It appears as if Mastercard Incorporated MA gave a large move recently.
Stock of Mastercard Incorporated (MA) is trading below an important moving average line, but it crossed this line recently, which means that it could show a small or a large recovery soon enough depending on its trend.
My analysis of Mastercard Incorporated is bearish for shortterm, and stock might move down till 552 or till 534.9. Use a stoploss of 566.28 and if the stock hits stoploss, then it can shoot up till 580.56
MA Mastercard Incorporated is falling or rising NEWS fundamental reasons
Tax shocker makes Nuvama downgrade ITC shares, says cigarette prices can go up 20% Nuvama cut ITC’s target price to Rs 415 and downgraded the stock to hold after the government announced a sharper-than-expected hike in cigarette taxes. The brokerage expects price hikes to hurt volumes and EBITDA from FY27, prompting earnings downgrades. - NEWS as on 2026-01-01 indiatimes.com
Obesity treatment drugs to be new growth engine for pharma industry: Sun Pharma India, known for its generic drug industry, is rapidly transforming into a major hub for global weight management industry, amid rapid increase in obesity-led disease burden. - NEWS as on 2025-12-28 indiatimes.com
Nuvama Wealth Management among 5 F&O stocks that saw a sharp rise in futures open interest As of December 24, five stocks in the NSE F&O segment witnessed a sharp rise in futures open interest, signalling increased derivatives activity. Rising open interest indicates fresh positions or expansion of existing bets, reflecting stronger trader p - NEWS as on 2025-12-26 indiatimes.com
Nuvama initiates coverage on Ashish Kacholia-backed stock with Rs 2,500 target, cites 3 bullish triggers Nuvama Institutional Equities has initiated coverage on Knowledge Marine & Engineering Works with a ‘Buy’ rating and a target price of Rs 2,500, citing strong maritime sector tailwinds, a robust order book, superior margins, and execution strength acro - NEWS as on 2025-12-24 indiatimes.com
Diabetes wave to fuel Indian pharma rally in 2026. Elara Capital picks 9 stocks for up to 43% gains Elara Capital sees GLP-1 drugs as a major tailwind for India’s pharma sector, potentially becoming first-line therapy for diabetes and obesity. The brokerage recommends buying five stocks, accumulating four others, and selling one amid shifting metabolic t - NEWS as on 2025-12-23 indiatimes.com
Emcure Pharma launches weight loss drug Poviztra in India Emcure Pharmaceuticals has launched Poviztra, a semaglutide injection for weight loss, becoming the first Indian company to exclusively distribute Novo Nordisk's medication. Available in a once-weekly pen device, Poviztra is indicated for chronic weight ma - NEWS as on 2025-12-22 indiatimes.com
VersaBank Names Nicolas Ospina Global CFO; Promotes CFO John Asma To EVP (RTTNews) - VersaBank (VBNK) on Friday announced that Nicolas Ospina has been appointed Global Chief Financial Officer with effect from January 5, 2026, in support of the bank's proposed restructuring to a standard U.S. bank framework. - NEWS as on 2025-12-19 nasdaq.com
India's pharma exports cross billion: Rajesh Agrawal India's pharmaceutical exports have surpassed billion in FY25. The nation stands as a trusted global supplier of quality and affordable medicines. India is the third largest producer by volume and 14th by value. Medicines reach over 200 markets. The do - NEWS as on 2025-12-18 indiatimes.com
Trial by fire: Over 60% of pharma SMEs may be forced to shut shop India is estimated to have about 12,000 drug manufacturing units. The units that risk being shut down account for about Rs 75,000 crore of India's Rs 2.5 lakh crore domestic drug market, the executives said. This may result in shortages of antibiotics, ant - NEWS as on 2025-12-16 indiatimes.com
More announcements and NEWS
MA Mastercard Incorporated current price & indicator signals
Recent prices of MA Mastercard Incorporated are as follows: Daily volume is divided by 10 day averaged volume
| Date | Close | Range | Change % | Volume |
| 02 Fri Jan 2026 | 563.13 | 559.49 to 570.88 | -1.36% | 1.67 times |
| 31 Wed Dec 2025 | 570.88 | 570.62 to 577.98 | -1.21% | 0.74 times |
| 29 Mon Dec 2025 | 577.90 | 577.41 to 581.99 | 0% | 0.54 times |
| 29 Mon Dec 2025 | 577.90 | 577.41 to 581.99 | -0.29% | 0.54 times |
| 26 Fri Dec 2025 | 579.60 | 578.68 to 581.20 | 0.03% | 0.42 times |
| 24 Wed Dec 2025 | 579.45 | 577.00 to 582.29 | 0.54% | 0.45 times |
| 23 Tue Dec 2025 | 576.35 | 575.75 to 581.72 | 0.11% | 0.77 times |
| 22 Mon Dec 2025 | 575.70 | 571.00 to 579.45 | 0.61% | 1.07 times |
| 19 Fri Dec 2025 | 572.23 | 565.20 to 572.94 | 1.06% | 3.1 times |
| 18 Thu Dec 2025 | 566.21 | 563.04 to 569.13 | 0.13% | 0.96 times |
| 17 Wed Dec 2025 | 565.47 | 563.55 to 571.76 | -0.1% | 1.4 times |
| 16 Tue Dec 2025 | 566.02 | 562.48 to 571.00 | -0.55% | 1.17 times |
Videos related to: MA NEWS why is Mastercard Incorporated price falling or rising
Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You
Hindi Basics How To Trade In FnO Futures Options Stock Market
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance
